Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocetirizine Continuous vs On Demand in Persistent Allergic Rhinitis
NCT00160680Phase 4Completed
- Sponsor
- UCB
- Start
- Mar 2005
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levocetirizine in persistent allergic rhinitis (PAR), sponsored by UCB. Started Mar 2005; status: completed.
02
Drugs
levocetirizine
03
Conditions
persistent allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00160680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160680.